Literature DB >> 32421201

Flow Cytometry-based Detection of B-cell Lymphoproliferative Disorders in Patients with Mycosis Fungoides.

Shamir Geller1, Sigi Kay, Eran Ellenbogen, Tomer Goldsmith, Shoshi Bar-On, Emily Warshauer, Varda Deutsch, Eli Sprecher, Chava Perry, Ilan Goldberg.   

Abstract

Entities:  

Keywords:  B-cell lymphoproliferative disorder; SLL/CLL; chronic lymphocytic leukemia/small lymphocytic lymphoma; flow cytometry; mycosis fungoides; cutaneous T-cell lymphoma

Mesh：

Year:  2020        PMID： 32421201      PMCID： PMC9175040          DOI： 10.2340/00015555-3517

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  10 in total

1.  Composite mycosis fungoides and B-cell chronic lymphocytic leukemia.

Authors:  Andrea L Volk; Stephen A Vannucci; William Cook; Keith A Thompson; Catherine M Listinsky
Journal:  Ann Diagn Pathol       Date:  2002-06       Impact factor: 2.090

2.  Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.

Authors:  Kathie P Huang; Martin A Weinstock; Christina A Clarke; Alex McMillan; Richard T Hoppe; Youn H Kim
Journal:  Arch Dermatol       Date:  2007-01

3.  Mycosis fungoides associated with B-cell malignancies.

Authors:  A Barzilai; H Trau; M David; M Feinmesser; R Bergman; D Shpiro; G Schiby; K Rosenblatt; R Or; E Hodak
Journal:  Br J Dermatol       Date:  2006-08       Impact factor: 9.302

4.  Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.

Authors:  Timothy W Chang; Amy L Weaver; Tait D Shanafelt; Thomas M Habermann; Cooper C Wriston; James R Cerhan; Timothy G Call; Jerry D Brewer
Journal:  Int J Dermatol       Date:  2017-07-07       Impact factor: 2.736

5.  Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.

Authors:  Kyle T Amber; Romi Bloom; Keyvan Nouri
Journal:  Am J Clin Dermatol       Date:  2016-02       Impact factor: 7.403

6.  Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.

Authors:  Amrita Goyal; Daniel O'Leary; Kavita Goyal; Nathan Rubin; Kimberly Bohjanen; Maria Hordinsky; Steven T Chen; Georgios Pongas; Lyn M Duncan; Aleksandr Lazaryan
Journal:  J Am Acad Dermatol       Date:  2019-07-30       Impact factor: 11.527

7.  Clonal chronic lymphocytic leukaemia-like B lymphocytes in the blood of patients with cutaneous T-cell disorders.

Authors:  S Daenen; P C van Voorst Vader; N Blom; J Pietens; H Hollema; J W Smit
Journal:  Br J Haematol       Date:  1993-10       Impact factor: 6.998

8.  Increased malignancy risk in the cutaneous T-cell lymphoma patient population.

Authors:  Isaac Brownell; Carol J Etzel; Deborah J Yang; Sarah H Taylor; Madeleine Duvic
Journal:  Clin Lymphoma Myeloma       Date:  2008-04

9.  Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.

Authors:  Elise Herro; David J Dicaudo; Mark D P Davis; Amy L Weaver; David L Swanson
Journal:  J Am Acad Dermatol       Date:  2009-05-28       Impact factor: 11.527

10.  Cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia: clinical characteristics, temporal relationships, and survival data in a series of 14 patients at Mayo Clinic.

Authors:  Michael B Chang; Amy L Weaver; Jerry D Brewer
Journal:  Int J Dermatol       Date:  2013-10-18       Impact factor: 2.736
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.